Literature DB >> 32016062

Carbapenem-resistant Klebsiella pneumoniae-impact of infection-prevention and control interventions.

Isabelle Vock1, Sarah Tschudin-Sutter1,2.   

Abstract

Entities:  

Year:  2019        PMID： 32016062      PMCID： PMC6976386          DOI： 10.21037/atm.2019.09.91

Source DB:  PubMed          Journal:  Ann Transl Med        ISSN： 2305-5839


× No keyword cloud information.
  14 in total

Review 1.  Deconstructing the infection control bundles for the containment of carbapenem-resistant Enterobacteriaceae.

Authors:  L Silvia Munoz-Price; John P Quinn
Journal:  Curr Opin Infect Dis       Date:  2013-08       Impact factor: 4.915

Review 2.  An ongoing national intervention to contain the spread of carbapenem-resistant enterobacteriaceae.

Authors:  Mitchell J Schwaber; Yehuda Carmeli
Journal:  Clin Infect Dis       Date:  2013-12-04       Impact factor: 9.079

Review 3.  Persisting intrahospital transmission of multidrug-resistant Klebsiella pneumoniae and challenges for infection control.

Authors:  Isabelle Vock; Sarah Tschudin-Sutter
Journal:  Infect Control Hosp Epidemiol       Date:  2019-06-11       Impact factor: 3.254

4.  Control of carbapenemase-producing Klebsiella pneumoniae: a region-wide intervention.

Authors:  C Gagliotti; V Cappelli; E Carretto; M Marchi; A Pan; P Ragni; M Sarti; R Suzzi; G A Tura; M L Moro
Journal:  Euro Surveill       Date:  2014-10-30

Review 5.  Carbapenem-resistant Enterobacteriaceae in the community: a scoping review.

Authors:  Ana M Kelly; Barun Mathema; Elaine L Larson
Journal:  Int J Antimicrob Agents       Date:  2017-06-21       Impact factor: 5.283

6.  Attributable mortality rate for carbapenem-resistant Klebsiella pneumoniae bacteremia.

Authors:  Abraham Borer; Lisa Saidel-Odes; Klaris Riesenberg; Seada Eskira; Nejama Peled; Ronit Nativ; Francisc Schlaeffer; Michael Sherf
Journal:  Infect Control Hosp Epidemiol       Date:  2009-10       Impact factor: 3.254

7.  Resistance trends among clinical isolates in China reported from CHINET surveillance of bacterial resistance, 2005-2014.

Authors:  F-P Hu; Y Guo; D-M Zhu; F Wang; X-F Jiang; Y-C Xu; X-J Zhang; C-X Zhang; P Ji; Y Xie; M Kang; C-Q Wang; A-M Wang; Y-H Xu; J-L Shen; Z-Y Sun; Z-J Chen; Y-X Ni; J-Y Sun; Y-Z Chu; S-F Tian; Z-D Hu; J Li; Y-S Yu; J Lin; B Shan; Y Du; Y Han; S Guo; L-H Wei; L Wu; H Zhang; J Kong; Y-J Hu; X-M Ai; C Zhuo; D-H Su; Q Yang; B Jia; W Huang
Journal:  Clin Microbiol Infect       Date:  2016-03       Impact factor: 8.067

8.  Nationwide Surveillance of Clinical Carbapenem-resistant Enterobacteriaceae (CRE) Strains in China.

Authors:  Rong Zhang; Lizhang Liu; Hongwei Zhou; Edward Waichi Chan; Jiaping Li; Ying Fang; Yi Li; Kang Liao; Sheng Chen
Journal:  EBioMedicine       Date:  2017-04-26       Impact factor: 8.143

9.  Control of Carbapenemase-producing Enterobacteriaceae: Beyond the Hospital.

Authors:  Vincent C C Cheng; Shuk-Ching Wong; Sally C Y Wong; Pak-Leung Ho; Kwok-Yung Yuen
Journal:  EClinicalMedicine       Date:  2019-01-07

10.  Control of Carbapenem-resistant Enterobacteriaceae, Acinetobacter baumannii, and Pseudomonas aeruginosa in Healthcare Facilities: A Systematic Review and Reanalysis of Quasi-experimental Studies.

Authors:  Sara Tomczyk; Veronica Zanichelli; M Lindsay Grayson; Anthony Twyman; Mohamed Abbas; Daniela Pires; Benedetta Allegranzi; Stephan Harbarth
Journal:  Clin Infect Dis       Date:  2019-02-15       Impact factor: 9.079
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.